Dr. Reddy's Laboratories Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Dr. Reddy's Laboratories stock has a consensus rating of "Hold" and an average price target of $14.14. The average 1-year stock price forecast is 6.32% higher than the current stock price, while the lowest is $11.39 (-14.36%) and the highest is $16.69 (+25.49%).

Price Target: $14.14 (+6.32%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$11.39	$14.14	$13.93	$16.69
Change	-14.36%	+6.32%	+4.74%	+25.49%

Analyst Ratings

The average analyst rating for Dr. Reddy's Laboratories stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jul '25	Oct '25	Dec '25	Jan '26	Apr '26	May '26
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	1	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	4	5	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst Citi No rating	Citi	Sell Maintains n/a	Sell	Maintains	n/a	n/a	Apr 23, 2026

Financial Forecast

Revenue This Year

356.97B

from 335.93B

6.26%

from 335.93B

Revenue Next Year

393.80B

from 356.97B

10.32%

from 356.97B

EPS This Year

52.91

from 55.39

-4.48%

from 55.39

EPS Next Year

64.51

from 52.91

21.93%

from 52.91

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	214.39B	245.88B	279.16B	325.54B	335.93B	356.97B
Revenue Growth	13.00%	14.69%	13.54%	16.61%	3.19%	6.26%
Gross Profit	113.84B	139.34B	163.61B	190.43B	177.26B	190.78B
Gross Margin	53.10%	56.67%	58.61%	58.50%	52.77%	53.45%
Operating Income	35.92B	53.42B	65.31B	72.01B	49.25B	51.11B
Net Income	23.57B	45.07B	55.68B	56.54B	42.85B	44.07B
EPS	-	-	-	-	55.39	52.91
EPS Growth	-	-	-	-	-20.06%	-4.48%
Forward PE	-	-	-	-	-	23.95
Dividend / Share	6.00	8.00	8.00	8.00	8.00	7.66
Dividend Growth	-	33.33%	-	-	-	-4.31%
Free Cash Flow	1.03B	29.68B	12.23B	11.28B	1.63B	42.62B
No. Analysts	-	-	-	-	-	37

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue	2027	2028	2029
High	390.4B
Avg	357.0B
Low	334.2B

Revenue Growth

Revenue Growth	2027	2028	2029
High	16.2%
Avg	6.3%
Low	-0.5%

EPS Forecast

EPS	2027	2028	2029
High	68.40
Avg	52.91
Low	41.20

EPS Growth

EPS Growth	2027	2028	2029
High	23.5%
Avg	-4.5%
Low	-25.6%